Applied therapeutics reports third quarter 2020 financial results

Continued enrollment in the arise-hf phase 3 global registrational study of at-001 in diabetic cardiomyopathy (fatal heart disease affecting ~17% diabetics)
APLT Ratings Summary
APLT Quant Ranking